StockDuty ← Dashboard Oct 02, 2026 04:12 PM ET
SignalCorporate

Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 as Thermo Fisher Scientific, Merck KGaA, Lonza and Samsung Biologics Accelerate Automation

Market projected to surge to $21.46 billion by 2030, with Thermo Fisher, Merck KGaA, Lonza, and Samsung Biologics accele

What changed
Market projected to surge to $21.46 billion by 2030, with Thermo Fisher, Merck KGaA, Lonza, and Samsung Biologics accele
Why it matters
Market projected to surge to $21.46 billion by 2030, with Thermo Fisher, Merck KGaA, Lonza, and Samsung Biologics accele — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →